RTTNews | Sep 28, 2021 08:13AM EDT

08:13 Tuesday, September 28, 2021 (RTTNews.com) - Outlook Therapeutics Reports New Positive 12-Month Safety Data From Pivotal Phase 3 NORSE TWO Trial

For comments and feedback: contact editorial@rttnews.com

https://www.rttnews.comCopyright(c) 2021 RTTNews.com All Rights Reserved